Invictus MD Strategies Corp (IVITF)

[a surfer]

Vancouver, BC, January 16, 2018 - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to reaffirm its increased target capacity to 76,000 kg based on expanding facilities in 2019 to approximately 520,000 square feet outlined on January 16, 2018. Dan Kriznic, Invictus MD Chairman and CEO stated, “The Company has achieved a number of important achievements, as we march towards fulfilling capacity goals during this historic and important year for Canada’s cannabis industry. We started this company in 2014 with the intention of becoming Canada’s Cannabis Company. With the granting of AB Laboratories Inc.’s sales license and the progress being made on the Phase 2 production facility at Acreage Pharms Ltd.’s, key constructions milestones in the drive towards that intent are being achieved. This dramatically advances our timeline for increasing our annual run-rate production capacity at our facilities to 26,000 kg in 2018 in time for the adult-use market. Invictus MD’s current cash balance is approximately $32 million.

The Company also reports that it has granted 1,100,000 incentive stock options to directors and consultants of the Company. The stock options are exercisable for a period of five years at an exercise price of $1.84 per share. The options were granted under, and are subject to the terms and conditions of the Company's Stock Option Plan.